News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

Considerations Prior to Start of Therapy

Episodes in this series

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 2 Detecting Melanoma That Has Spread

EP. 2 Detecting Melanoma That Has Spread

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 6 Top Concerns of Patients

EP. 6 Top Concerns of Patients

EP. 7 Additional Approaches in Advanced Melanoma

EP. 7 Additional Approaches in Advanced Melanoma

Newsletter

Stay up to date on cancer updates, research and education

Related Content

A nurse practitioner explains how FDA approval of subcutaneous Rybrevant may reduce treatment burden and improve care for patients with EGFR-mutated lung cancer.

Expert Discusses FDA Approval of Chemo-Free Option for EGFR-Mutated Lung Cancer

BySpencer Feldman

February 11th 2026

pediatric cancer

Childhood Cancer Survivors Face Long-Term Meningioma Risk

February 11th 2026

Man

How Caregivers Can Help Loved Ones With Lung Cancer Feel in Control

BySpencer Feldman

February 11th 2026

Laura.

How Cancer Stole My Peace of Mind and Taught Me Resilience

February 11th 2026

Mary Royal and Dr. Pablo Prichard

MRD Testing May Offer Peace of Mind to Breast Cancer Survivors

ByMary Royal,Dr. Pablo Prichard

February 11th 2026

Trending on CURE

Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer

Why Subcutaneous Darzalex Faspro Matters for Patients With Multiple Myeloma

FDA Clears PD-L1 Test to Guide Keytruda Use in Ovarian Cancer

MRD Testing May Offer Peace of Mind to Breast Cancer Survivors

FDA Clears Phase 2b Study of Teverelix in Advanced Prostate Cancer